Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-25-017156
Filing Date
2025-10-06
Accepted
2025-10-06 18:51:16
Documents
1
Period of Report
2025-09-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3941
  Complete submission text file 0001493152-25-017156.txt   5694
Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 856-848-8698
Q/C TECHNOLOGIES, INC. (Issuer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 780 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10017
Business Address
Bernstein Bruce (Reporting) CIK: 0001665472 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36268 | Film No.: 251377961